Health Trials

Nephroblastoma

2

Review clinical trials related to Nephroblastoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, BCOR-driven sarcoma, or another solid tumor that makes a higher than normal amount of XPO1 or has genetic changes that increase the activity of XP01.

Participants needed: 45
Trial details
Phase: Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: May 6, 2026Locations: 16
Eligibility criteria

Age ≥ 6 at the time of informed consent [+31]

Prior Therapy: Has received selinexor or another XPO1 inhibitor previously. [+5]

Read more
Status: Recruiting

Therapeutic Recommendations for Nephroblastoma

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Participants needed: 1,000
Trial details
Age: 6-18Biological sex: AllType: ObservationalSponsor: French Africa Pediatric Oncology GroupUpdated: Mar 2, 2026Locations: 7
Eligibility criteria

Not listed

Read more